The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

BPaL-based regimens for MDR/RR-TB and pre-XDR-TB are safe and highly effective in non-trial settings. These regimens should be considered for widespread implementation globally, and further research is needed to evaluate their performance in other key populations.

Authors

Institutions

Publication Details

Journal
Clinical Infectious Diseases
Published
2025-02-18
DOI
https://doi.org/10.1093/cid/ciaf035
Citations
8
Primary Topic
Tuberculosis Research and Epidemiology
Type
article
Field-Weighted Citation Impact
11.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

Varvara Solodovnikova, Animesh A. Sinha, Jose Luis Alvarez, Alena Skrahina et al.
8 citations
Clinical Infectious Diseases
Tuberculosis Research and Epidemiology
11.17
article

The Effectiveness and Safety of Bedaquiline, Pretomanid, and Linezolid (BPaL)–Based Regimens for Rifampicin-Resistant Tuberculosis in Non-Trial Settings—A Prospective Cohort Study in Belarus and Uzbekistan

Varvara Solodovnikova, Animesh A. Sinha, Jose Luis Alvarez, Alena Skrahina, Norman Sitali, Nathalie Lachenal, Natalia Yatskevich, Robert J. Klebe, S. Moe, Zinaida Tigay, Nargiza Parpieva, Fatimata Bintou Sall, Nazgul Samieva, Dzmitry Viatushka, Sholpan Allamuratova, Matthew J Saunders, Khasan Safaev, Muzaffar Achilov, Corinne Merle, Irina Liverko, Cecilio Tan, A. Khristusev, Camilo Gomez Restrepo, Michael L. Rekart, Sanjar Mirzabaev
article en
8 citations

Abstract

BPaL-based regimens for MDR/RR-TB and pre-XDR-TB are safe and highly effective in non-trial settings. These regimens should be considered for widespread implementation globally, and further research is needed to evaluate their performance in other key populations.

Clinical Infectious DiseasesVol. 81(4)
Médecins Sans Frontières (UG), St George's, University of London (GB), World Health Organization (CH), Wuhan Pulmonary Hospital (CN), Republican Scientific and Practical Centre of Pulmonology and Tuberculosis (BY), Médecins Sans Frontières‎ (GB), Médecins Sans Frontières (CH), Médecins Sans Frontières (US), Tashkent Pediatric Medical Institute (UZ), City St George's, University of London (GB)
Global Fund to Fight AIDS, Tuberculosis and Malaria, Médecins Sans Frontières
Good health and well-being
Openalex Percentile: Top 1%
Tuberculosis Research and Epidemiology
11.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.